Zambrano B - Search Results

1

Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules.

López EL, Contrini MM, Xifró MC, Cattaneo MA, Zambrano B, Dumas R, Rouyrre N, Weber F. López EL, et al. Among authors: zambrano b. Vaccine. 2007 Jan 2;25(1):102-8. doi: 10.1016/j.vaccine.2006.07.014. Epub 2006 Jul 28. Vaccine. 2007. PMID: 16914234 Clinical Trial.

2

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.

Castillo de Febres O, Chacon de Petrola M, Casanova de Escalona L, Naveda O, Naveda M, Estopinan M, Bordones G, Zambrano B, Garcia A, Dumas R. Castillo de Febres O, et al. Among authors: zambrano b. Vaccine. 1999 Nov 12;18(7-8):656-64. doi: 10.1016/s0264-410x(99)00272-8. Vaccine. 1999. PMID: 10547425 Clinical Trial.

3

Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.

Lagos R, Munoz A, Dumas R, Pichon S, Zambrano B, Levine M, Vidor E. Lagos R, et al. Among authors: zambrano b. Vaccine. 2003 Sep 8;21(25-26):3730-3. doi: 10.1016/s0264-410x(03)00385-2. Vaccine. 2003. PMID: 12922104 Clinical Trial.

4

Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10-45 years.

Tregnaghi MW, Voelker R, Santos-Lima E, Zambrano B. Tregnaghi MW, et al. Among authors: zambrano b. Vaccine. 2010 Apr 30;28(20):3595-601. doi: 10.1016/j.vaccine.2010.02.049. Epub 2010 Feb 26. Vaccine. 2010. PMID: 20189492 Clinical Trial.

5

A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children.

Aquino AG, Brito MG, Doniz CE, Herrera JF, Macias M, Zambrano B, Plennevaux E, Santos-Lima E. Aquino AG, et al. Among authors: zambrano b. Vaccine. 2012 Oct 5;30(45):6492-500. doi: 10.1016/j.vaccine.2012.07.040. Epub 2012 Jul 31. Vaccine. 2012. PMID: 22863658 Clinical Trial.

6

Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.

Tregnaghi M, Zambrano B, Santos-Lima E. Tregnaghi M, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2012 Jan;31(1):e24-30. doi: 10.1097/INF.0b013e318242460a. Pediatr Infect Dis J. 2012. PMID: 22157567

7

Immunogenicity and safety of tetravalent dengue vaccine in 2-11 year-olds previously vaccinated against yellow fever: randomized, controlled, phase II study in Piura, Peru.

Lanata CF, Andrade T, Gil AI, Terrones C, Valladolid O, Zambrano B, Saville M, Crevat D. Lanata CF, et al. Among authors: zambrano b. Vaccine. 2012 Sep 7;30(41):5935-41. doi: 10.1016/j.vaccine.2012.07.043. Epub 2012 Jul 31. Vaccine. 2012. PMID: 22863660 Clinical Trial.

8

Immunogenicity and safety of an investigational hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-hepatitis B-Haemophilus influenzae B conjugate combined vaccine in healthy 2-, 4-, and 6-month-old Argentinean infants.

Tregnaghi MW, Zambrano B, Santos-Lima E. Tregnaghi MW, et al. Among authors: zambrano b. Pediatr Infect Dis J. 2011 Jun;30(6):e88-96. doi: 10.1097/INF.0b013e318212eb80. Pediatr Infect Dis J. 2011. PMID: 21372751 Clinical Trial.

9

Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.

Dayan GH, Langevin E, Forrat R, Zambrano B, Noriega F, Frago C, Bouckenooghe A, Machabert T, Savarino S, DiazGranados CA. Dayan GH, et al. Among authors: zambrano b. Vaccine. 2020 Sep 22;38(41):6472-6477. doi: 10.1016/j.vaccine.2020.07.056. Epub 2020 Aug 6. Vaccine. 2020. PMID: 32773243 Free article.

10

Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.

Coronel-MartÍnez DL, Park J, López-Medina E, Capeding MR, Cadena Bonfanti AA, Montalbán MC, Ramírez I, Gonzales MLA, DiazGranados CA, Zambrano B, Dayan G, Savarino S, Chen Z, Wang H, Sun S, Bonaparte M, Rojas A, Ramírez JC, Verdan MA, Noriega F. Coronel-MartÍnez DL, et al. Among authors: zambrano b. Lancet Infect Dis. 2021 Apr;21(4):517-528. doi: 10.1016/S1473-3099(20)30767-2. Epub 2020 Nov 16. Lancet Infect Dis. 2021. PMID: 33212067 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters